Applied BioCode Corp
TWSE:6598
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| TW |
|
Applied BioCode Corp
TWSE:6598
|
2.4B TWD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.9B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
124.7B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.3B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.9B EUR |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.2B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.4B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD |
Loading...
|
Market Distribution
| Min | -197.7% |
| 30th Percentile | 13.7% |
| Median | 22.1% |
| 70th Percentile | 31.4% |
| Max | 400.8% |
Other Profitability Ratios
Applied BioCode Corp
Glance View
Applied BioCode Corp. designs, develops, manufactures and commercializes multiplex testing products for in-vitro diagnostics market. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-09. The firm's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The firm sells in the United States, Europe and Asia markets.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Applied BioCode Corp is 54.9%, which is below its 3-year median of 62.3%.
Over the last 3 years, Applied BioCode Corp’s Gross Margin has decreased from 60% to 54.9%. During this period, it reached a low of 54.9% on Jan 1, 2026 and a high of 69% on Jun 30, 2024.
